$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of the effect of regorafenib in the treatment of gastrointestinal stromal tumors
2026-02-01 22:25:32
Check Details
What is the standard dosage of pazopanib/pazopanib?
2026-02-01 22:25:32
Check Details
A guide to precautions for Parkinson’s patients taking Opicapone
2026-02-01 22:25:32
Check Details
The domestic and overseas listing status and price of fenelidone
2026-02-01 22:25:32
Check Details
Which manufacturer produces better rasagiline? Any recommendations?
2026-02-01 22:25:32
Check Details
The latest clinical research progress of pimetibi
2026-02-01 22:25:32
Check Details
What is the correct dosage for using mobosetinib/mobosetinib
2026-02-01 22:25:32
Check Details
Detailed explanation of the dosage and administration of tepotinib: how to adjust the dosage regimen
2026-02-01 22:25:32
Check Details
What examinations are required during regorafenib treatment?
2026-02-01 22:25:32
Check Details
What is the brand name of pazopanib/pazopanib? How to get
2026-02-01 22:25:32
Check Details
Evaluation of the efficacy and safety of long-term use of Opicapone
2026-02-01 22:25:32
Check Details
Remedies and precautions after missing doses of fenelidone
2026-02-01 22:25:32
Check Details
1
2
...
1683
1684
1685
1686
1687
1688
1689
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
2
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
3
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection
4
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
5
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
6
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
7
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
8
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
9
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
10
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
11
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
12
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia